Orakl Oncology
Series AVillejuif, FranceNov 2026
Orakl Oncology raised €31M in a Series A round in Nov 2026. The company is based in Villejuif, France. Investors in the round: Norrsken VC, Singular. Data as of Nov 2026.
Amount raised
€31M
€30,683,151
Native amount
34,000,000 USD
Stage
Series A
series a
Investors
2
Provenance & confidence
High confidenceAmount
34,000,000 USD
ECB-at-date → €31M · rate 1.1081 on 2026-11-12
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.